Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 13/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.46 |
| ▸ | ACLY | P53396 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30901134 | 0.82 | F2 (0.57) | ALDH1A1LMNAKMT2ACA2CA12 | |
| SCHEMBL1436244 | 0.82 | F2 (0.57) | ALDH1A1LMNAKMT2ACA2CA12 | |
| SCHEMBL4638087 | 0.82 | ALDH1A1 (0.57) | ALDH1A1LMNAKMT2ASMN1; SMN2HTT | |
| SCHEMBL212547 | 0.82 | ALDH1A1 (0.57) | ALDH1A1LMNAKMT2ASMN1; SMN2HTT | |
| SCHEMBL3653439 | 0.81 | MEN1 (0.65) | ALDH1A1LMNAKMT2ASMN1; SMN2HTT | |
| SCHEMBL11769980 | 0.81 | CA2 (0.53) | ALDH1A1LMNAKMT2ASMN1; SMN2HTT | |
| SCHEMBL533063 | 0.81 | ALDH1A1 (0.55) | ALDH1A1LMNAKMT2ASMN1; SMN2HTT | |
| SCHEMBL11585746 | 0.81 | ALDH1A1 (0.55) | ALDH1A1LMNAKMT2ASMN1; SMN2HTT | |
| SCHEMBL3347957 | 0.81 | CA2 (0.63) | ALDH1A1LMNAKMT2ASMN1; SMN2CA2 | |
| SCHEMBL31439621 | 0.81 | F2 (0.56) | ALDH1A1LMNAKMT2ACA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1858540-A2 | STABILIZED COMPOSITIONS CONTAINING NATRIURETIC PEPTIDES | Bio-Rad Laboratories, Inc. (US) | 2007-11-28 | — | — | EP | claimed |
| WO-2006088624-A2 | STABILIZED COMPOSITIONS CONTAINING NATRIURETIC PEPTIDES | BIO-RAD LABORATORIES, INC. (US) | 2006-08-24 | — | — | WO | claimed |
| US-20060183681-A1 | Stabilized compositions containing natriuretic peptides | BIO-RAD LABORATORIES, INC. (US) | 2006-08-17 | — | — | US | claimed |
| US-20200158739-A1 | METHOD, COMPOSITION AND DEVICE FOR SAMPLING NATRIURETIC PEPTIDES IN A BIOLOGICAL FLUID | QUIDEL CORPORATION | 2020-05-21 | — | — | US | disclosed |
| US-10641781-B2 | Method, composition and device for sampling natriuretic peptides in a biological fluid | CRIMSON U.S. ASSETS LLC (US) | 2020-05-05 | — | — | US | disclosed |
| US-20170003305-A1 | METHOD, COMPOSITION AND DEVICE FOR SAMPLING NATRIURETIC PEPTIDES IN A BIOLOGICAL FLUID | CRIMSON U.S. ASSETS LLC (US) | 2017-01-05 | — | — | US | disclosed |
| US-9482677-B2 | Method, composition and device for sampling natriuretic peptides in a biological fluid | SCIOS INC. (US) | 2016-11-01 | — | — | US | disclosed |
| EP-2098866-B1 | Method, composition and device for sampling natriuretic peptides in a biological fluid | SCIOS INC (US) | 2013-05-01 | — | — | EP | disclosed |
| EP-2098866-A1 | Method, composition and device for sampling natriuretic peptides in a biological fluid | Scios Inc. (US) | 2009-09-09 | — | — | EP | disclosed |
| US-20090215182-A1 | METHOD, COMPOSITION AND DEVICE FOR SAMPLING NATRIURETIC PEPTIDES IN A BIOLOGICAL FLUID | QUIDEL CORPORATION | 2009-08-27 | — | — | US | disclosed |
| EP-1858540-A2 | STABILIZED COMPOSITIONS CONTAINING NATRIURETIC PEPTIDES | Bio-Rad Laboratories, Inc. (US) | 2007-11-28 | — | — | EP | disclosed |
| US-6037362-A | CARBAZOLE DERIVATIVES; DEPROTECTING, AMINATION; ANTILIPEMIC AND ANTIDIABETIC AGENTS; B-ADRENALINE RECEPTOR AGONISTS; DIETETICS | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 2000-03-14 | — | — | US | disclosed |
| US-5973156-A | Piperidine and tetrahydropyridine derivatives | MERCK SHARP & DOME LTD. (GB) | 1999-10-26 | — | — | US | disclosed |
| EP-0882707-A1 | NOVEL TRICYCLIC COMPOUNDS AND DRUG COMPOSITIONS CONTAINING THE SAME | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1998-12-09 | — | — | EP | disclosed |
| EP-0861245-A1 | PIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES | MERCK SHARP & DOHME LTD. (GB) | 1998-09-02 | — | — | EP | disclosed |
| WO-1997019073-A1 | PIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES | MERCK SHARP & DOHME LIMITED (GB) | 1997-05-29 | — | — | WO | disclosed |
| US-5459131-A | Renin inhibitors | AMERICAN CYANAMID COMPANY (US) | 1995-10-17 | — | — | US | disclosed |
| EP-0206714-B1 | PROCESS FOR THE PREPARATION OF AN AMINE TERMINATED POLYBUTADIENE | ELF ATOCHEM S.A. (FR) | 1991-03-13 | — | — | EP | disclosed |
| EP-0206714-A1 | Process for the preparation of an amine terminated polybutadiene | ELF ATOCHEM S.A. (FR) | 1986-12-30 | — | — | EP | disclosed |
| US-4065459-A | SULFONATION | PARCOR (FR) | 1977-12-27 | — | — | US | disclosed |